EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST), an Exton-based manufacturer of injectable drug packaging and delivery components with $3.07 billion in annual sales, will present at the Jefferies Global Healthcare Conference in London on Nov. 18, providing investors an opportunity to hear from the company as it operates a global manufacturing network serving pharmaceutical developers.
The presentation is scheduled for 8 a.m. Greenwich Mean Time on Wednesday, Nov. 18, 2026, the company announced.
Investors and analysts can access a live audio webcast through the Investors section of West’s website at www.westpharma.com. A replay will remain available for approximately 90 days after the presentation.
West supplies components, devices and services used in the containment and administration of injectable medications, working with established pharmaceutical manufacturers and emerging drug developers.
The company employs more than 10,000 people across 50 locations worldwide, including 26 manufacturing facilities.
Its operations support the production and distribution of more than 41 billion pharmaceutical components and devices annually, reflecting its role in the global supply chain for injectable medicines.
West reported $3.07 billion in net sales for fiscal 2025. The company is listed on the New York Stock Exchange and is a constituent of the S&P 500 index.
The Jefferies conference brings together healthcare companies and institutional investors, providing a forum for discussions about business operations and industry developments.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.